**Question:** In Polycythemia Vera, all the following are seen except-

A. Increased hemoglobin levels
B. Increased hematocrit levels
C. Increased red blood cell mass
D. Increased red blood cell production

**Core Concept:**

Polycythemia Vera is a myeloproliferative neoplasm characterized by uncontrolled production of red blood cells (erythropoiesis). The condition is caused by a genetic mutation in the JAK2 gene, leading to overactivation of the JAK2/STAT5 pathway and increased erythropoietin production. As a result, the bone marrow produces excessive amounts of red blood cells, leading to increased hemoglobin, hematocrit levels, red blood cell mass, and red blood cell production.

**Why the Correct Answer is Right:**

In Polycythemia Vera, the bone marrow produces excessive red blood cells due to the genetic mutation in the JAK2 gene and the subsequent overactivation of the JAK2/STAT5 pathway and increased erythropoietin production. This leads to the typical clinical manifestations of the condition, such as increased hemoglobin, hematocrit levels, red blood cell mass, and red blood cell production.

**Why Each Wrong Option is Incorrect:**

A. Increased hemoglobin levels: This is a characteristic feature of Polycythemia Vera, as the overproduction of red blood cells leads to increased hemoglobin levels.
B. Increased hematocrit levels: Hematocrit is a measure of the proportion of red blood cells in the blood and is also increased in Polycythemia Vera due to increased hemoglobin levels.
C. Increased red blood cell mass: The increased hemoglobin and hematocrit levels in Polycythemia Vera result in an increased red blood cell mass.
D. Increased red blood cell production: Polycythemia Vera is characterized by excessive red blood cell production due to the genetic mutation in the JAK2 gene and the subsequent overactivation of the JAK2/STAT5 pathway and increased erythropoietin production.

**Clinical Pearl:** Polycythemia Vera is a myeloproliferative disorder caused by a genetic mutation in the JAK2 gene leading to overactivation of the JAK2/STAT5 pathway and increased erythropoietin production. This results in the characteristic feature of increased hemoglobin, hematocrit levels, red blood cell mass, and red blood cell production.